Abolis Biotechnologies is an industrial biotechnology company that uses synthetic biology and metabolic engineering to design microbial strains and fermentation processes for producing bio-based ingredients and specialty chemicals. The company develops tailored biomanufacturing routes that can replace or complement traditional petrochemical pathways.
Working with partners across the chemical, cosmetics, nutrition, and healthcare sectors, Abolis provides end-to-end capabilities from pathway design and strain construction to process development, scale-up, and technology transfer for commercial production. Its work spans molecules such as performance and fine chemicals, cosmetic actives, and flavor and fragrance ingredients, with a focus on delivering consistent quality and industrial feasibility through scalable fermentation and downstream processing.
